SARS and MERS: recent insights into emerging coronaviruses
By E. de Wit, Neeltje van Doremalen, D. Falzarano, V. Munster. Nature Reviews Microbiology, 2016
3,317 citations recorded by the source corpus.
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. The continuing introductions of MERS-CoV from dromedary camels, the subsequent travel-related viral spread, the unprecedented nosocomial outbreaks and the high case-fatality rates highlight the need for prophylactic and therapeutic measures. Scientific advancements since the 2002–2003 severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic allowed for rapid progress in our understanding of the epidemiology and pathogenesis of MERS-CoV and the development of therapeutics. In this Review, we detail our present understanding of the transmission and pathogenesis of SARS-CoV and MERS-CoV, and discuss the current state of development of measures to combat emerging coronaviruses.
Subfields: Infectious Diseases, Modeling and Simulation
View Paper: https://www.semanticscholar.org/paper/c377338a2eb14de7671d992d4c1aa735bb661617
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
- Jun Zheng
- Hannah Kleine-Weber
- Scott Weaver
- Yu Chen
- S. Pöhlmann
- Christian Drosten
- David Gurwitz
- M. Hoffmann
In Modeling and Simulation
Citations in the corpus
- Coronavirus disease 2019 (COVID-19): current status and future perspectives (2020, background): “In both of these epidemics, these viruses are likely originated from bats and then infect humans through another intermediate animal hosts [the civet (Paguma larvata) for SARS-CoV and the camel for MERS-CoV] [8-10].”
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV (2020, background): “A vaccine against SARS-CoV has not been described in any published articles [66].”
- Parental Engagement in Children's Online Learning During COVID-19 Pandemic (2020, background): “%) or influenza pandemic (same as in the years 1957 and 1968) and not a disease similar to SARS or MERS, which has the rate of death cases from 9 to 10% and 36% (De Wit et al., 2016).”
- Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients (2020, background): “It is believed that dysregulated host immune response and production of inflammatory cytokines, known as the "cytokine storm", correlates with disease severity and poor prognosis during SARS-CoV and MERS-CoV infection [8, 9, 14] .”
- Coronavirus Disease 2019 (COVID-19): A Perspective from China (2020, background): “ARDS= acute respiratory distress syndrome COVID-19 = Coronavirus Disease 19 GGO = ground-glass opacity MERS = Middle East respiratory syndrome RT-PCR = reverse-transcription–polymerase-chain-reaction SARS = severe acute respiratory syndrome SARS-CoV-2 = severe acute respiratory syndrome coronavirus ”
- SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat (2020, background): “3%) is much lower than SARS (~10%) and MERS (~36%) [26,27].”
- Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia (2020, background): “But further surveillance studies indicated that these animals are rarely positive for SARS coronavirus in non-market settings, suggesting that they only served as intermediate hosts in the SARS event (1, 7).”